Socrates reports that recently completed tests have confirmed the functionality of the Socrates Noninvasive Blood Glucose Self-Monitoring Technology at a precision of microradians (µrads) necessary to correlate to measurements from 50 mg/dL to 500 mg/dL—the practical range of sensitivity required for daily diabetes management. “These results reflect that this intellectual property protected (IPP) methodology for […]
Socrates Health Solutions, Inc., which is developing the Socrates Companion, a pain-free, accurate and affordable noninvasive blood glucose monitoring device, based on exclusively licensed technology, announced today the US Patent and Trademark Office (USPTO) has granted K Sciences a patent for a new, noninvasive technique for monitoring blood glucose. September 30, 2014 BOSTON GLOBE FINANCIAL […]
Socrates Health Solutions which is developing the Socrates CompanionTM, a pain-free, accurate and affordable noninvasive blood glucose monitoring device, announces the appointment of Douglas Sutherland to its Board of Directors. An active investor in diabetes-related start-up companies, Sutherland has held senior leadership positions at high-profile global companies and is currently serving as the Non-executive Chairman […]
Socrates Health Solutions released results of recent human testing. The data, as expected, confirmed the capabilities of the Socrates technology across a broader range of glucose levels in human subjects including diabetics. This data set demonstrates the company’s continued progress towards its end-state of the Socrates Companion design. April 11, 2018 DALLAS–(BUSINESS WIRE)–
Socrates Health Solutions announces the appointment of John Maynard to the role of special advisor, bringing to Socrates more than 25 years of experience developing and commercializing non-invasive medical diagnostic devices. Maynard was a co-founder and executive vice president of VeraLight which commercialized SCOUT DS, a non-invasive diabetes screening device. Prior to VeraLight, he was […]
